Loading clinical trials...
Loading clinical trials...
The aim of the study is to evaluate whether oral administration of 200 mg/day lactoferrin (LF) to very low birth weight infants reduces late onset sepsis and necrotising enterocolitis and the effect o...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ankara University
NCT07192393 · Prematurity; Extreme, Prematurity; Decision Support, and more
NCT06092463 · Preterm Infants, Term Infants, and more
NCT06965842 · Premature Infants, Very Low Birth Weight Infants
NCT05530330 · Late-Onset Neonatal Sepsis, Necrotising Enterocolitis, and more
NCT06870318 · Human Milk Fortification, Very Low Birth Weight Baby, and more
Ankara University School of Medicine Department of Pediatrics, NICU
Ankara
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions